AYTU BIOPHARMA, INC Payments to Acquire Assets, Investing Activities
AYTU BIOPHARMA, INC (AYTU) reported Payments to Acquire Assets, Investing Activities of $2.34 million for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAssetsInvestingActivities · last filed 2022-05-16
- AYTU BIOPHARMA, INC payments to acquire assets, investing activities for the quarter ending 2021-06-30 was -$13.06M.
- AYTU BIOPHARMA, INC payments to acquire assets, investing activities for fiscal 2021 was $2.34M.
- AYTU BIOPHARMA, INC payments to acquire assets, investing activities for fiscal 2020 was $0.00.
| Period end | Payments to Acquire Assets, Investing Activities 3 month | Payments to Acquire Assets, Investing Activities 9 month | Payments to Acquire Assets, Investing Activities 12 month |
|---|---|---|---|
| 2021-06-30 | -$13.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $2.34M 10-K · filed 2021-09-28 | |
| 2021-03-31 | $15.40M 10-Q · filed 2022-05-16 | ||
| 2020-06-30 | $0.00 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |